An Injectable Hydrogel Platform for Sustained Delivery of Anti-inflammatory Nanocarriers and Induction of Regulatory T Cells in Atherosclerosis is a research paper published in Frontiers in Bioengineering and Biotechnology (2020). On theSindex it has a DataRank of 0. It has been cited 36 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 1DP2HL132390-01
Development of combination immunotherapies for atherosclerotic inflammation
National Science Foundation
Grant: CAREER-1453576
National Science Foundation
Grant: CBET-1806007
NIGMS NIH HHS
Grant: T32 GM144295
NIGMS NIH HHS
Grant: T32 GM008152
NHLBI NIH HHS
Grant: DP2 HL132390
NIGMS NIH HHS
Grant: T32 GM105538
NICHD NIH HHS
Grant: T32 HD094699
National Science Foundation
Grant: 1453576
CAREER: Rational design of a biomimetic nanomaterial library to probe mechanisms behind virus-induced immunopathology
National Science Foundation
Grant: 1806007
Investigating the impact of tumor heterogeneity on sustained low dosage immunotherapy via a peritumoral immunotheranostic hydrogel
FWCI
1.50
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals